Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVS save search
The Gastrointestinal OTC Drugs Market to grow by USD 4,759.86 million from 2022 to 2027|Increase in the prevalence of gastrointestinal disorders to boost the market- Technavio
Published: 2023-07-25 (Crawled : 04:00) - prnewswire.com
HLN | $8.35 -0.71% 0.0% 5.2M
|
n/a
|
| O: 0.46%
H: 0.57%
C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.12%
H: 0.0%
C: -1.16%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.88%
H: 0.0%
C: 0.0%
PBH | $70.13 -1.53% 0.0% 170K
|
Health Technology
|
| O: -0.54%
H: 2.33%
C: 2.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.64%
H: 1.58%
C: 1.35%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.48%
H: 0.83%
C: 0.39%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
gastrointestinal market
Global Eylea Market Sees Impressive Growth with Major Players Regeneron Pharmaceuticals, Bayer AG, and More Expanding Research and Development Efforts
Published: 2023-07-24 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.88%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.66%
H: 0.43%
C: -1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.64%
H: 1.58%
C: 1.35%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.54%
H: 1.31%
C: 0.92%
eylea research global growth market
Sandoz receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab
Published: 2023-07-24 (Crawled : 06:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.05%
H: 0.24%
C: -0.83%
biosimilar chmp positive sclerosis
Major Players Abbott, Pfizer, and Novartis Drive Growth in Global Hormone Therapy Market to 2032
Published: 2023-07-21 (Crawled : 23:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
global novartis therapy growth market hormone
Major Players Merck & Co, Roche, and Pfizer Fuel Growth of Global 5-Alpha Reductase Deficiency Market to 2032
Published: 2023-07-21 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
merck global growth market
Acrivon Therapeutics Announces the Appointment of Adam Levy, Ph.D., M.B.A., Experienced Biotech Investor Relations and Strategy Executive, to Senior Vice President and Head, Investor Relations and Corporate Affairs
Published: 2023-07-20 (Crawled : 12:00) - globenewswire.com
ACRV | $9.46 -3.67% -3.81% 300K
|
|
| O: -3.91%
H: 4.07%
C: 3.12%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 2.78%
H: 0.0%
C: -1.86%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.51%
H: 0.72%
C: 0.33%
biotech therapeutics
Sandoz announces plans to build a Biosimilar Technical Development Center in Slovenia to support future growth of biosimilar pipeline
Published: 2023-07-20 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 2.78%
H: 0.0%
C: -1.86%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.51%
H: 0.72%
C: 0.33%
biosimilar pipeline growth
Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.47%
H: 1.47%
C: 1.47%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.97%
H: 0.0%
C: 0.0%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 1.23%
H: 4.13%
C: 4.01%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.61%
H: 0.6%
C: -0.84%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.19%
H: 1.19%
C: -0.1%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.5%
H: 0.75%
C: -0.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.18%
H: 0.67%
C: -0.4%
drug reach research market
Global Calcium Channel Blocker Market Expected to Reach $14.66 Billion in 2023, Fueled by Increasing Prevalence of Cardiovascular Diseases
Published: 2023-07-18 (Crawled : 22:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.97%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.61%
H: 0.6%
C: -0.84%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: 0.53%
H: 1.37%
C: -2.21%
expected reach global cardiovascular market
Novartis delivers strong sales growth, robust margin expansion and raises guidance. Announces USD 15 billion share buyback and Board endorses Sandoz spin-off[1],[2]
Published: 2023-07-18 (Crawled : 05:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.65%
H: 5.27%
C: 5.27%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.92%
H: 2.33%
C: 1.6%
sales expansion novartis
Effervescent Tablet Market to Grow at a CAGR of 5.12% from 2021 to 2026|ALPEX PHARMA SA, Amerilab Technologies Inc, Bayer AG, and more to emerge as key players -Technavio
Published: 2023-07-18 (Crawled : 02:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: -1.69%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.65%
H: 5.27%
C: 5.27%
RBGLY | News | $10.59 -2.05% 850K
|
Manufacturing
|
| O: -0.26%
H: 0.59%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.92%
H: 2.33%
C: 1.6%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.46%
H: 0.95%
C: 0.37%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: -0.04%
H: 0.06%
C: -0.67%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: -0.12%
H: 0.07%
C: -0.66%
pharma market
Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers
Published: 2023-07-12 (Crawled : 12:20) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.49%
C: 0.26%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
hope beacon education novartis trial
Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio
Published: 2023-07-12 (Crawled : 05:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.98%
H: 0.97%
C: -1.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.49%
C: 0.26%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.96%
H: 0.52%
C: -0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
set market
Multiple Myeloma Drugs Market to grow by USD 6,419.94 million from 2022 to 2027|Growing incidence of multiple myeloma boosts the market growth - Technavio
Published: 2023-07-10 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -3.53%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.23%
H: 0.4%
C: 0.4%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.18%
H: 0.7%
C: 0.62%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.36%
H: 1.31%
C: 1.17%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.0%
H: 0.62%
C: 0.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.4%
H: 0.78%
C: 0.01%
growth market
US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease
Published: 2023-07-10 (Crawled : 12:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.44%
H: 0.73%
C: 0.48%
leqvio fda disease treatment risk novartis heart
Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook
Published: 2023-07-07 (Crawled : 20:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
entresto novartis
Biologics CDMO Market to grow by USD 13.26 billion from 2022 to 2027 | Research and development pipeline of biologics therapeutics to boost the market - Technavio
Published: 2023-07-06 (Crawled : 00:00) - prnewswire.com
JSCPY | $28.01 -25.66% 2.5K
|
n/a
|
| O: 0.69%
H: 1.96%
C: 1.23%
GIKLY | $4.4 132.75% 150
|
Manufacturing
|
| O: -2.72%
H: 1.51%
C: 1.51%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.16%
H: 0.27%
C: -3.19%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.07%
H: 0.36%
C: -1.2%
pipeline research therapeutics market
Biosimilars Market Research Report 2023 - Global Forecast to 2028 - Patent Expiries of Blockbuster Biologics and Research into New Indications Presents Opportunities
Published: 2023-07-05 (Crawled : 00:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.17%
H: 0.63%
C: 0.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.55%
H: 0.97%
C: 0.02%
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: -2.54%
H: 10.78%
C: 10.04%
AMPH | $40.98 0.17% 0.17% 220K
|
Health Technology
|
| O: -0.52%
H: 1.38%
C: -0.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.43%
H: 0.48%
C: -0.86%
patent report research global market
Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight
Published: 2023-07-05 (Crawled : 21:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.86%
H: 0.0%
C: -1.01%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.17%
H: 0.63%
C: 0.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.55%
H: 0.97%
C: 0.02%
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: -6.72%
OPK | $1.225 -2.0% -2.04% 6.1M
|
Health Technology
|
| O: -1.19%
H: 1.2%
C: -0.72%
ADXS | $0.54 12.48% 950
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.83%
cancer global growth market
Pharmaceutical Drug Delivery Market to Reach $2,307.27 Billion, Globally, by 2032 at 4.4% CAGR: Allied Market Research
Published: 2023-07-05 (Crawled : 14:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.18%
H: 0.21%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.74%
H: 0.1%
C: -0.86%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.61%
H: 0.06%
C: -0.51%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.16%
H: 1.18%
C: 0.54%
drug reach research market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.